AFMD - Affimed to Participate in Upcoming Investor Conferences | Benzinga
MANNHEIM, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed" or the "Company"), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the Company's management will participate in the following investor conferences during the month of November 2023.
Truist Securities BioPharma Symposium (November 8-9, 2023)
Date: Wednesday, November 8, 2023
One-on-one meetings only
Location: New York, NY
Jefferies London Healthcare Conference (November 14-16, 2023)
Date: Wednesday, November 15, 2023
Presentation Time: 8:30 a.m. EST / 1:30 p.m. ...